Keybanc analyst Michael Turits maintains Workday (NASDAQ:WDAY) with a Overweight and raises the price target from $195 to $215.
Analyst Ratings for SpringWorks Therapeutics
SpringWorks Therapeutics (NASDAQ:SWTX) has observed the following analyst ratings within the last quarter: Bullish Somewhat Bullish Indifferent Somewhat…